business
Stifel raises MBX Biosciences stock price target to $56 on obesity data
Stifel raises MBX Biosciences stock price target to $56 on obesity data
Read full story on Investing.com → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop